1. Home
  2. ABEO vs ORN Comparison

ABEO vs ORN Comparison

Compare ABEO & ORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • ORN
  • Stock Information
  • Founded
  • ABEO N/A
  • ORN 1994
  • Country
  • ABEO United States
  • ORN United States
  • Employees
  • ABEO N/A
  • ORN N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • ORN Military/Government/Technical
  • Sector
  • ABEO Health Care
  • ORN Industrials
  • Exchange
  • ABEO Nasdaq
  • ORN Nasdaq
  • Market Cap
  • ABEO 277.6M
  • ORN 254.8M
  • IPO Year
  • ABEO 1980
  • ORN 2007
  • Fundamental
  • Price
  • ABEO $6.27
  • ORN $5.62
  • Analyst Decision
  • ABEO Strong Buy
  • ORN Strong Buy
  • Analyst Count
  • ABEO 3
  • ORN 2
  • Target Price
  • ABEO $18.00
  • ORN $13.25
  • AVG Volume (30 Days)
  • ABEO 289.4K
  • ORN 474.5K
  • Earning Date
  • ABEO 11-11-2024
  • ORN 10-30-2024
  • Dividend Yield
  • ABEO N/A
  • ORN N/A
  • EPS Growth
  • ABEO N/A
  • ORN N/A
  • EPS
  • ABEO N/A
  • ORN N/A
  • Revenue
  • ABEO N/A
  • ORN $722,909,000.00
  • Revenue This Year
  • ABEO N/A
  • ORN $21.06
  • Revenue Next Year
  • ABEO $7,097.06
  • ORN $11.56
  • P/E Ratio
  • ABEO N/A
  • ORN N/A
  • Revenue Growth
  • ABEO 147.52
  • ORN 0.33
  • 52 Week Low
  • ABEO $3.05
  • ORN $4.09
  • 52 Week High
  • ABEO $9.01
  • ORN $12.12
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 56.31
  • ORN 39.81
  • Support Level
  • ABEO $6.39
  • ORN $5.83
  • Resistance Level
  • ABEO $6.74
  • ORN $6.23
  • Average True Range (ATR)
  • ABEO 0.30
  • ORN 0.28
  • MACD
  • ABEO -0.01
  • ORN 0.04
  • Stochastic Oscillator
  • ABEO 52.04
  • ORN 39.20

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.

About ORN Orion Group Holdings Inc. Common

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar, and mesh across the light commercial, structural and other associated business areas.

Share on Social Networks: